Page last updated: 2024-08-23
paclitaxel and bkt140
paclitaxel has been researched along with bkt140 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Abraham, M; Beider, K; Eizenberg, O; Fahham, D; Hanna, W; Izhar, U; Peled, A; Shapira, OM; Shlomai, Z; Wald, O; Weiss, ID; Zamir, G | 1 |
Other Studies
1 other study(ies) available for paclitaxel and bkt140
| Article | Year |
|---|---|
In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL2; Chemoradiotherapy; Cisplatin; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Mice; Mice, Nude; Oligopeptides; Paclitaxel; Receptors, CXCR4; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |